Atlas Trials

Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)

Clinical trial NCT05881135 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05881135
Sponsor
Ohio State University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2023-06-06
Primary completion
2025-03-17
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.